Medicine, prevention, nutrition, mental health, healthy aging, health technology, health policy, and the regulation of supplements.
The World Health Organization's 2025 ICOPE handbook places capacity checks at the start of a pathway that continues through assessment, a care plan and monitoring. Grip and gait can flag possible decline, but neither measurement establishes a diagnosis or identifies its cause.
WHO's July 2025 position paper recommends herpes zoster vaccination for older adults where shingles is an important public health problem. Countries still set their own age, coverage and access rules, while recombinant vaccine requires a two-dose course.
Taiwan-based Repurgenesis said in late July 2026 that it had signed a memorandum of understanding with Switzerland-based Medvisis to pursue AI-assisted drug repurposing. The public announcement names a platform and a commercial network, but not a candidate, dataset, validation plan or binding development milestone.
The World Health Organization published an updated COVID-19 vaccine position paper on July 31, 2026, with recommendations organized by risk group and national context. A practical adult vaccine review starts with documented doses, then applies the age, pregnancy, health, work and travel rules used where care is received.
The World Health Organization's European office said on July 24, 2026, that adults should apply approved mosquito repellent to young children and keep it off their hands, eyes and mouth. Age limits differ among countries, so the locally authorized label must guide product choice and application.
The UK's medicines regulator announced stronger addiction, dependence, withdrawal and tolerance warnings for benzodiazepines and Z-drugs on January 8, 2026. It said abrupt cessation can trigger withdrawal and that tapering should be gradual, individualized and adjusted when symptoms become intolerable.
The World Health Organization classifies children under five as being at higher risk of severe influenza and calls for antiviral treatment as soon as possible in high-risk cases. Breathing problems, reduced alertness or dehydration require immediate care, while medicine and school-return rules vary by country.
The fifth European Code Against Cancer recommends organized low-dose CT screening for higher-risk adults aged 55 to 74, typically those with a smoking history. Rules in the United States and England draw different eligibility lines, while false positives, repeat scans and overdiagnosis remain part of the tradeoff.
A 2025 guideline from the US Departments of Veterans Affairs and Defense recommends CBT-I for chronic insomnia and suggests it over medication as first-line care. The therapy combines behavioral and cognitive work, while sleep restriction can temporarily increase daytime sleepiness and requires an individualized plan.
A positive fecal immunochemical test means blood was detected in a stool sample, but it does not diagnose colorectal cancer. The result usually leads to colonoscopy because another stool sample cannot locate the bleeding source or remove a precancerous lesion.
An April 2026 BMJ Open audit rated 49.6 percent of 250 responses from five consumer chatbots as problematic when tested with misinformation-prone health prompts. Consumers can reduce that risk by checking the exact claim against regulator records, matching it to human evidence and opening every cited source.
The World Health Organization's 2025 ICOPE handbook places a six-area capacity screen at the start of a four-stage primary care pathway for older adults. Studies in Spain and Taiwan found that results varied by domain and tool version, limiting what a one-time screen can establish.
A July 2026 review found only low- or very-low-certainty evidence for exosome-based nonsurgical facial rejuvenation. Evidence for products labeled with exosomes, NAD+, stem cells or peptides depends on the formulation, route and outcome, not the laboratory term alone.
A 2025 systematic review found that all six included studies, covering 689 children, reported gains in at least one developmental domain. No randomized trials were included, and WHO-UNICEF guidance says a concerning screen must lead to assessment and tracked follow-up rather than serve as a diagnosis.
World Medical Association guidance reaffirmed in October 2024 tells physicians to give evidence-based information and avoid recommending unproven products in media. A doctor's appearance, a ‘clinically proven’ label and a patent answer different questions, and none alone establishes a supplement's claimed effect.
The World Health Organization's healthy-diet guidance, updated on January 26, 2026, gives adults managing blood pressure, glucose or cholesterol a shared set of priorities. It favors whole grains, pulses, fruit and vegetables while limiting sodium, free sugars, saturated fat and trans fat, but clinical targets still vary.
The European Union's 2024 annual report said a screening found that 97 percent of the influencers checked posted commercial content, but only one in five consistently identified it as advertising. For supplement posts, a sponsorship label identifies a commercial tie; it does not show that a health claim matches regulator records or human evidence.
The World Health Organization's July 31, 2026 guidance says heat-related deaths and hospital admissions can rise on the day of an extreme-heat event and in the days that follow. A household plan should connect local warnings to cooling, fluids and rest, with earlier action for children, older adults and people with chronic illness.
